
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
Jul 30, 2026 00:22 am UTC| Business
Starbucks (NASDAQ: SBUX) delivered stronger-than-expected third-quarter results, fueled by solid customer traffic growth in North America and improving operational performance under its ongoing turnaround strategy. The...

OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
Jul 30, 2026 00:20 am UTC| Business Technology
OpenAI has reportedly reached a major financial milestone, with its annualized recurring revenue (ARR) in July exceeding the revenue generated during the entire second quarter of 2026. The update, shared by Chief Financial...

Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Jul 30, 2026 00:17 am UTC| Business Technology
Arm Holdings delivered stronger-than-expected first-quarter fiscal 2027 results, beating Wall Street estimates on both earnings and revenue while issuing an upbeat outlook for the current quarter. Despite the solid...

Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Jul 30, 2026 00:10 am UTC| Business
Chipotle Mexican Grill (NYSE: CMG) exceeded Wall Street expectations for the second quarter of 2026, reporting stronger-than-expected earnings and revenue fueled by new restaurant openings, higher customer spending, and...

Qualcomm Stock Falls as Weak Q4 Forecast, Apple Revenue Decline Overshadow AI Data Center Growth
Jul 30, 2026 00:08 am UTC| Business Technology
Qualcomm (NASDAQ: QCOM) shares dropped more than 4% in after-hours trading after the chipmaker issued a weaker-than-expected fiscal fourth-quarter profit forecast and warned that revenue from Apple-related products will...

Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
Jul 29, 2026 04:17 am UTC| Business
Standard Chartered (StanChart) reported stronger-than-expected first-half earnings on Wednesday, driven by solid growth across its wealth management, markets, and global banking businesses. The emerging markets-focused...

GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Jul 29, 2026 04:11 am UTC| Business Health
GSK has announced a 1.9 billion ($2.52 billion) cost-savings initiative aimed at accelerating drug development and strengthening its long-term growth strategy as the British pharmaceutical giant prepares for the loss of...